Sébastien Perreault

Author

Sébastien Perreault

Centre Hospitalier Universitaire Sainte-Justine ORCID

Also Known As

Aylsworth, Arthur S., Perreault Sébastien, Perreault, Sebastien, Perreault, Sébastien, S Perreault, S. Perreault, Sbastien Perreault, Sebastien Perreault, Sebastién Perreault, Starr, Lois J.

215

Publications

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire Sainte-Justine Université de Montréal Hospital for Sick Children University of Toronto Université Laval

About

Sébastien Perreault is an author at Centre Hospitalier Universitaire Sainte-Justine specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	1.8K
2	Health Sciences	3	3	69
3	Cell Biology	3	3	288
4	Arts	1	1	34
5	Social Sciences	1	1	70

Sébastien Perreault

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis Vijay Ramaswamy, Marc Remke, Éric Bouffet, The Lancet Oncology Neuro-oncologyTumoral PathologyOncologyTumor HeterogeneityRecurrence Patterns	2013	393
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis Eric M. Thompson, Thomas Hielscher, Éric Bouffet, The Lancet Oncology Neuro-oncologySurgical OncologyMedulloblastoma ExtentMolecular SubgroupMedicine	2016	356
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype Timothy N. Phoenix, Deanna M. Patmore, Scott Boop, Cancer Cell Neuro-oncologyNeuroscienceNeurologyBrain LesionBrain Pathology	2016	332
MRI Surrogates for Molecular Subgroups of Medulloblastoma Sébastien Perreault, Vijay Ramaswamy, Achal S. Achrol, American Journal of Neuroradiology	2014	320
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors François Doz, Cornelis M. van Tilburg, Birgit Geoerger, Neuro-Oncology	2021	154
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas Selin Jessa, Abdulshakour Mohammadnia, Ashot S. Harutyunyan, Nature Genetics Neuro-oncologyBrain Midline GliomasGliomaNeuroscienceMolecular Neurobiology	2022	153
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial Lindsay Kilburn, Dong-Anh Khuong-Quang, Jordan R. Hansford, Nature Medicine	2023	146
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01 Sébastien Perreault, Valérie Larouche, Uri Tabori, BMC Cancer	2019	144
MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma Michael Iv, Mu Zhou, Katie Shpanskaya, American Journal of Neuroradiology	2018	124
Trametinib for progressive pediatric low-grade gliomas Maria Kondyli, Valérie Larouche, Christine Saint‐Martin, Journal of Neuro-Oncology Neuro-oncologyPediatric Brain TumorsPediatric NeurosurgeryMedicinePediatric Neuro-oncology	2018	100

Page 1